NASDAQ:GLPG Galapagos (GLPG) Stock Price, News & Analysis → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free GLPG Stock Alerts $28.55 -0.22 (-0.76%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$28.55▼$29.0450-Day Range$28.45▼$34.7152-Week Range$28.30▼$45.21Volume75,533 shsAverage Volume148,467 shsMarket Capitalization$1.88 billionP/E RatioN/ADividend YieldN/APrice Target$34.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Galapagos alerts: Email Address Galapagos MarketRank™ Stock AnalysisAnalyst RatingReduce1.75 Rating ScoreUpside/Downside20.8% Upside$34.50 Price TargetShort InterestBearish2.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.15Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.12) to $0.22 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.47 out of 5 starsMedical Sector876th out of 921 stocksPharmaceutical Preparations Industry411th out of 428 stocks 1.9 Analyst's Opinion Consensus RatingGalapagos has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageGalapagos has only been the subject of 2 research reports in the past 90 days.Read more about Galapagos' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted2.41% of the float of Galapagos has been sold short.Short Interest Ratio / Days to CoverGalapagos has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.Change versus previous monthShort interest in Galapagos has recently increased by 4.67%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldGalapagos does not currently pay a dividend.Dividend GrowthGalapagos does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GLPG. Previous Next 2.3 News and Social Media Coverage News SentimentGalapagos has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Galapagos this week, compared to 2 articles on an average week.Search Interest2 people have searched for GLPG on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Galapagos to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Galapagos insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.91% of the stock of Galapagos is held by insiders.Percentage Held by InstitutionsOnly 32.46% of the stock of Galapagos is held by institutions.Read more about Galapagos' insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Galapagos are expected to grow in the coming year, from ($0.12) to $0.22 per share.Price to Book Value per Share RatioGalapagos has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Galapagos' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Chaikin AnalyticsA.I. is a Tidal Wave - Here’s What to BuyThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. About Galapagos Stock (NASDAQ:GLPG)Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.Read More GLPG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GLPG Stock News HeadlinesMay 6, 2024 | finance.yahoo.comGalapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call TranscriptMay 5, 2024 | markets.businessinsider.comKepler Capital Sticks to Their Hold Rating for Galapagos (GLPG)May 11, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.May 4, 2024 | finance.yahoo.comGalapagos First Quarter 2024 Earnings: EPS: €0.36 (vs €0.35 in 1Q 2023)May 4, 2024 | americanbankingnews.comGalapagos NV (NASDAQ:GLPG) Receives Average Recommendation of "Hold" from AnalystsMay 3, 2024 | americanbankingnews.comGalapagos (NASDAQ:GLPG) Sets New 12-Month Low at $28.30May 2, 2024 | globenewswire.comGalapagos reports first quarter 2024 financial resultsMay 1, 2024 | americanbankingnews.comGalapagos NV (NASDAQ:GLPG) Sees Significant Increase in Short InterestMay 11, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 30, 2024 | finance.yahoo.comGalapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024April 30, 2024 | globenewswire.comGalapagos' shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024April 4, 2024 | globenewswire.comGalapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024April 1, 2024 | msn.comGalapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: AnalystApril 1, 2024 | finance.yahoo.comGalapagos Full Year 2023 Earnings: Beats ExpectationsMarch 28, 2024 | finanznachrichten.deGalapagos NV: Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' MeetingsMarch 28, 2024 | finance.yahoo.comGalapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsMarch 28, 2024 | globenewswire.comGalapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' MeetingsMarch 28, 2024 | finanznachrichten.deGalapagos NV: Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardMarch 28, 2024 | msn.comBofA downgrades Galapagos to Underperform over lack of catalysts in the near termMarch 26, 2024 | globenewswire.comGalapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardMarch 20, 2024 | nasdaq.comGalapagos Enters Oversold Territory (GLPG)March 16, 2024 | finance.yahoo.comGLPG Oct 2024 45.000 putMarch 16, 2024 | finance.yahoo.comGLPG Apr 2024 42.500 putMarch 7, 2024 | seekingalpha.comGalapagos: Pipeline Still Progressing Despite Financial VolatilityMarch 7, 2024 | realmoney.thestreet.comGalapagos assumed with an Equal Weight at Morgan StanleyMarch 3, 2024 | finance.yahoo.comGLPG Mar 2024 32.500 putFebruary 27, 2024 | realmoney.thestreet.comGalapagos price target lowered by EUR 4 at BarclaysSee More Headlines Receive GLPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galapagos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/10/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GLPG CUSIPN/A CIK1421876 Webwww.glpg.com Phone(321) 534-2900Fax321-534-2901Employees1,123Year Founded1999Price Target and Rating Average Stock Price Target$34.50 High Stock Price Target$38.00 Low Stock Price Target$31.00 Potential Upside/Downside+20.8%Consensus RatingReduce Rating Score (0-4)1.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($2.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$229.12 million Net Margins-26.25% Pretax Margin2.35% Return on Equity-2.60% Return on Assets-1.46% Debt Debt-to-Equity RatioN/A Current Ratio9.02 Quick Ratio8.84 Sales & Book Value Annual Sales$243.58 million Price / Sales7.72 Cash Flow$0.64 per share Price / Cash Flow44.68 Book Value$45.92 per share Price / Book0.62Miscellaneous Outstanding Shares65,897,000Free Float63,979,000Market Cap$1.88 billion OptionableOptionable Beta0.27 Social Links These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Paulus A. Stoffels M.D. (Age 62)Ph.D., CEO, Chairman, Interim Head of R&D Comp: $1.34MMr. Thad Huston (Age 53)Executive VP, CFO & COO Ms. Sofie Van GijselHead of Investor RelationsMs. Valeria Cnossen (Age 50)Executive VP & General Counsel Marieke VermeerschHead of Corporate CommunicationMs. Annelies Missotten (Age 51)Executive VP & Chief Human Resources Officer Ms. Ellen Van Der AarHead of DevelopmentMr. Philippe Alen M.B.A.Ph.D., Pharm.D., Senior VP & Head of Business DevelopmentMr. Dirk De NaeyerHead of Development OperationsMs. Alice DietrichHead of Medical AffairsMore ExecutivesKey CompetitorsNewAmsterdam PharmaNASDAQ:NAMSSyndax PharmaceuticalsNASDAQ:SNDXAgios PharmaceuticalsNASDAQ:AGIOEdgewise TherapeuticsNASDAQ:EWTXStructure TherapeuticsNASDAQ:GPCRView All CompetitorsInstitutional OwnershipAcadian Asset Management LLCBought 2,366 shares on 5/10/2024Ownership: 0.023%Monaco Asset Management SAMBought 10,000 shares on 5/9/2024Ownership: 0.025%Headlands Technologies LLCBought 712 shares on 5/8/2024Ownership: 0.001%BNP Paribas Financial MarketsBought 4,725 shares on 5/1/2024Ownership: 0.008%China Universal Asset Management Co. Ltd.Bought 1,504 shares on 4/29/2024Ownership: 0.006%View All Institutional Transactions GLPG Stock Analysis - Frequently Asked Questions Should I buy or sell Galapagos stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Galapagos in the last twelve months. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" GLPG shares. View GLPG analyst ratings or view top-rated stocks. What is Galapagos' stock price target for 2024? 4 brokerages have issued 1-year price targets for Galapagos' stock. Their GLPG share price targets range from $31.00 to $38.00. On average, they expect the company's stock price to reach $34.50 in the next twelve months. This suggests a possible upside of 20.8% from the stock's current price. View analysts price targets for GLPG or view top-rated stocks among Wall Street analysts. How have GLPG shares performed in 2024? Galapagos' stock was trading at $40.65 on January 1st, 2024. Since then, GLPG stock has decreased by 29.8% and is now trading at $28.55. View the best growth stocks for 2024 here. When is Galapagos' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our GLPG earnings forecast. What ETFs hold Galapagos' stock? ETFs with the largest weight of Galapagos (NASDAQ:GLPG) stock in their portfolio include ALPS Medical Breakthroughs ETF (SBIO).ERShares NextGen Entrepreneurs ETF (ERSX). What is Onno van de Stolpe's approval rating as Galapagos' CEO? 6 employees have rated Galapagos Chief Executive Officer Onno van de Stolpe on Glassdoor.com. Onno van de Stolpe has an approval rating of 100% among the company's employees. This puts Onno van de Stolpe in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Galapagos own? Based on aggregate information from My MarketBeat watchlists, some companies that other Galapagos investors own include Gilead Sciences (GILD), Celyad Oncology (CYAD), Intercept Pharmaceuticals (ICPT), NVIDIA (NVDA), argenx (ARGX), AbbVie (ABBV), Biogen (BIIB), Pharming Group (PHGUF), Trade Desk (TTD) and Collegium Pharmaceutical (COLL). When did Galapagos IPO? Galapagos (GLPG) raised $161 million in an initial public offering (IPO) on Thursday, May 14th 2015. The company issued 3,800,000 shares at a price of $42.43 per share. Morgan Stanley, Credit Suisse and Cowen and Company acted as the underwriters for the IPO and Nomura and Bryan, Garnier were co-managers. Who are Galapagos' major shareholders? Galapagos' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Monaco Asset Management SAM (0.03%), Acadian Asset Management LLC (0.02%), BNP Paribas Financial Markets (0.01%), China Universal Asset Management Co. Ltd. (0.01%), Headlands Technologies LLC (0.00%) and GAMMA Investing LLC (0.00%). How do I buy shares of Galapagos? Shares of GLPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GLPG) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galapagos NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
